Wouldn't sexually active people who have sex with men be the primary market? It makes sense this would be the focus of the drug's development.

They may also have issues trying to conduct robust clinical trials with IV drug abusers. If a subject entered rehab or were incarcerated for a period of the trial, would that invalidate their data? I don't know enough about the subject but it intuitively feels like it could present a real challenge.